AGP Executive Report
Last update: 12 hours agoNew Clinical Insight: A new study on tacrolimus dosing in connective tissue disease–associated interstitial lung disease highlights how tailoring initial doses could improve outcomes, but also underscores big differences between patients. Pain Management in Surgery: Research comparing liposomal bupivacaine, ropivacaine, and patient-controlled IV analgesia after VATS surgery adds fresh data on postoperative pain control and recovery. Infectious Disease Watch: Hong Kong’s CHP is investigating a confirmed mpox case and is urging vigilance after a rise in infections, including vaccination and safer-contact practices. Public Health & Safety: A dog bite incident in Yuen Long is being followed up after a fatal attack; authorities completed a dog capture operation and are pursuing licensing and control violations. Nutrition & Supplements: Industry speakers warn omega-3 supply decisions are getting harder due to El Niño impacts and EU packaging rules, pushing brands toward new formats and sourcing strategies. Local Health & Caregiving: Monaco’s Terrae rooftop and school/hospital farming projects have ended as the company enters liquidation, though the founder says education and therapeutic work will continue.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
